Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Biosimilar Medicines	489.68M	Log In	Log In
Biosimilar Medicines Growth	435.56%	Log In	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	273.04M	Log In	Log In
Europe	157.59M	Log In	Log In
Europe Growth	148.13%	Log In	Log In
Rest of World	59.06M	Log In	Log In
North America	-	Log In	Log In
North America Growth	-	Log In	Log In
Asia and Other	-	Log In	Log In
Asia	-	Log In	Log In
Other	-	Log In	Log In